These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23942562)

  • 1. [Are the recommendations on tuberculosis screening still valid? Interferon gamma release assay (IGRA) and/or tuberculin skin test for diagnosis of latent tuberculosis infection (LTBI)].
    Ernst D; Witte T; Schmidt RE; Meyer-Olson D
    Z Rheumatol; 2013 Nov; 72(9):846-50. PubMed ID: 23942562
    [No Abstract]   [Full Text] [Related]  

  • 2. Tuberculosis screening prior to anti-tumor necrosis factor therapy among patients with immune-mediated inflammatory diseases in Japan: a longitudinal study using a large-scale health insurance claims database.
    Tomio J; Yamana H; Matsui H; Yamashita H; Yoshiyama T; Yasunaga H
    Int J Rheum Dis; 2017 Nov; 20(11):1674-1683. PubMed ID: 29076252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the QuantiFERON®-TB Gold In-Tube Assay and Tuberculin Skin Test for the Diagnosis of Latent Tuberculosis Infection in an Iranian Referral Hospital.
    Pourakbari B; Yousefi K; Mahmoudi S; Sadeghi RH; Mamishi S
    Infect Disord Drug Targets; 2019; 19(2):141-144. PubMed ID: 29493468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis screening among HIV-infected patients: tuberculin skin test vs. interferon-gamma release assay.
    Adams JW; Howe CJ; Andrews AC; Allen SL; Vinnard C
    AIDS Care; 2017 Dec; 29(12):1504-1509. PubMed ID: 28486818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening for latent tuberculosis infection in patients with chronic inflammatory arthritis: discrepancies between tuberculin skin test and interferon-γ release assay results.
    Costantino F; de Carvalho Bittencourt M; Rat AC; Loeuille D; Dintinger H; Béné MC; Faure G; Chary-Valckenaere I
    J Rheumatol; 2013 Dec; 40(12):1986-93. PubMed ID: 24085550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of tuberculin skin test and interferon gamma release assay in pediatric candidates of heart transplantation and a 2-year follow-up.
    Sayyahfar S; Mahdavi M; Seyedi Arani S; Fotovati Z
    Transpl Infect Dis; 2020 Jun; 22(3):e13268. PubMed ID: 32072713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating UK National Guidance for Screening of Children for Tuberculosis. A Prospective Multicenter Study.
    Kampmann B; Seddon JA; Paton J; Nademi Z; Keane D; Williams B; Williams A; Liebeschutz S; Riddell A; Bernatoniene J; Patel S; Martinez N; McMaster P; Basu-Roy R; Welch SB
    Am J Respir Crit Care Med; 2018 Apr; 197(8):1058-1064. PubMed ID: 29190430
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a commercial interferon-gamma release assay and tuberculin skin test for the detection of latent tuberculosis infection in Hong Kong arthritis patients who are candidates for biologic agents.
    So H; Yuen CS; Yip RM
    Hong Kong Med J; 2017 Jun; 23(3):246-50. PubMed ID: 28126971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. QuantiFERON-TB Gold+ for the Diagnosis of Mycobacterium tuberculosis Infection.
    Yancey JR; Melchert VE
    Am Fam Physician; 2021 Feb; 103(3):177-178. PubMed ID: 33507050
    [No Abstract]   [Full Text] [Related]  

  • 11. Screening for latent tuberculosis in Norwegian health care workers: high frequency of discordant tuberculin skin test positive and interferon-gamma release assay negative results.
    Gran G; Aßmus J; Dyrhol-Riise AM
    BMC Public Health; 2013 Apr; 13():353. PubMed ID: 23590619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The predictive value of interferon-γ release assays and tuberculin skin test: what about those not vaccinated with Bacillus Calmette-Guérin?
    Hernández-Garduño E; Huitrón Bravo GG
    Chest; 2013 May; 143(5):1514-1515. PubMed ID: 23648924
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of two gamma interferon release assays and tuberculin skin testing for tuberculosis screening in a cohort of patients with rheumatic diseases starting anti-tumor necrosis factor therapy.
    Vassilopoulos D; Tsikrika S; Hatzara C; Podia V; Kandili A; Stamoulis N; Hadziyannis E
    Clin Vaccine Immunol; 2011 Dec; 18(12):2102-8. PubMed ID: 21994356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions.
    Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C
    Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of the tuberculin skin test and interferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches.
    Goletti D; Sanduzzi A; Delogu G
    J Rheumatol Suppl; 2014 May; 91():24-31. PubMed ID: 24788997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening of latent tuberculosis infection among health care workers working in Hajj pilgrimage area in Saudi Arabia, using interferon gamma release assay and tuberculin skin test.
    Bukhary ZA; Amer SM; Emara MM; Abdalla ME; Ali SA
    Ann Saudi Med; 2018; 38(2):90-96. PubMed ID: 29620541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-γ release assay versus tuberculin skin test for monitoring TB infection in healthcare workers.
    Nienhaus A; Ringshausen FC; Costa JT; Schablon A; Tripodi D
    Expert Rev Anti Infect Ther; 2013 Jan; 11(1):37-48. PubMed ID: 23428101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fewer losses in the cascade of care for latent tuberculosis with solo interferon-gamma release assay screening compared to sequential screening.
    Lim RK; Talavlikar R; Chiazor O; Bietz J; Gardiner H; Fisher D
    BMC Infect Dis; 2021 Sep; 21(1):936. PubMed ID: 34503458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discordance between the QuantiFERON-TB Gold In-Tube and Tuberculin Skin Test: need for a further step?
    Spinicci M; Mencarini J; Goletti D; Mantella A; Della Malva N; Bartoloni A; Bartalesi F
    Eur Respir J; 2015 Nov; 46(5):1506-9. PubMed ID: 26206879
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.